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The International Federation of Gyneacology and Obstetrics (FIGO)
deﬁnes microinvasive squamous cell carcinoma of the uterine cervix
as a microscopic lesion that invades below the basement membrane
to a maximum depth of 5 mm, with a horizontal spread not exceeding
7 mm with two subcategories: stage IA1 is a tumour that invades to a
depth of 3 mmor less, whereas IA2 is deﬁned as a tumour which invades
to a depth of 3 to 5 mm. The purpose of deﬁningmicroinvasive carcinoma
is to identify a group of patients who are not at risk for lymph node me-
tastases or tumour recurrence andwho, therefore,may be treated conser-
vatively. With women delaying pregnancy, conservative treatment for
microinvasive carcinoma of the cervix is increasingly important for pres-
ervation of fertility.We report here a case of uterine corpusmetastasis in a
patient with FIGO stage IA1 squamous cervical carcinoma of the cervix.
Case report
The patient is a 32-year-old Para 4, whohad undergone laparoscopic
sterilisation. She was referred to colposcopy due to a ﬁnding of severe
dyskaryosis on a ﬁrst abnormal smear. Loop biopsy in June 2009
(25 × 20 × 15 mm in size) showed 2 foci of invasive disease and in-
completely excised CIN3. The total dimensions of the invasive foci’Gorman Building, Newcastle University,
4HH, UK.
.uk (R.J. Edmondson).
Elsevier Inc.Open access under CC BY-NC-ND license.were b1 mm deep and 3.5 mm in width and were completely excised.
There was no evidence of LVSI. The tumour was therefore graded as a
FIGO stage IA1 squamous cell carcinoma. A second loop biopsy was
performed in July 2009 in view of the incompletely excised CIN3, and
this showed no residual invasive or pre-invasive disease. The case was
reviewed by a multidisciplinary team, and no further treatment was
recommended, in line with current UK practice.
The patient, however, chose to undergo a hysterectomy for menor-
rhagia and a laparoscopically assisted hysterectomy was performed in
September 2009. Histological examination of the cervix showed no re-
sidual pre-invasive or invasive disease. The endocervix and paracervical
tissues appeared normal. Given the history, all of the cervix was
processed for histology, and the uterine body elsewhere was sampled.
The cervix was processed as consecutive parallel blocks. The cervix
appeared distorted to the naked eye, but no gross abnormality was
seen in the uterus otherwise. However sampling of the endometrium
found a single small focus of squamous epithelial dysplasia, giving rise
to minimally invasive keratinising squamous carcinoma. The focus of
tumour was found in the body of the uterus in the right lateral position
and had no direct continuity with the cervix. The focus was entirely su-
perﬁcial and measured 1 mm in transverse dimension and less than
1 mm deep. There was no LVSI and the myometrium appeared normal.
Following discussion the attending physicians recommended no further
treatment. The patient is undergoing follow up in our unit after the
hysterectomy and remains well after four years of follow up (Fig. 1).
Discussion
The purpose of deﬁning stage IA1 cervical cancer is to identify those
cancer patients who may safely be managed more conservatively and
who have an excellent prognosis. It is generally accepted that FIGO
stage IA1 disease can be managed conservatively (Lee et al., 2009).
The incidence of microinvasive cervical cancer has increased over
the past few decades and the numbers of patients undergoing conserva-
tive treatment are also increasing in response to the apparent low recur-
rent and metastasis rates in microinvasive disease. However, review of
the literature demonstrates emerging evidence for metastasis in stage
IA1 cervical cancer. Nagarsheth et al. (2000) described a case of stage
IA1 cervical adenocarcinomawith bilateral pelvic lymph node metasta-
ses and Elliott et al. (2000) described a case where the tumour had stro-
mal invasion of 0.1 mm with less than 7 mm lateral spread and no
capillary space involvement. The patient did however have lymph
node metastases and ultimately succumbed to the disease. Argenta
Fig. 1.H&E stained cervical images (A&B) from LLETZ specimen and endometrial (C,D,E) sections of the specimen from hysterectomy. A - Cervical epithelium demonstrating CIN3 (black
arrow) and a focus of early stromal invasion (blue arrow) (100× magniﬁcation). B - Early stromal invasion (blue arrow) (400× magniﬁcation). C - Endometrial section demonstrating
small focus of squamous cell carcinoma (SCC) (40× magniﬁcation). D - Superﬁcial SCC (200× magniﬁcation) and E (400× magniﬁcation).
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ting ofmultifocalmicroinvasive squamous cell cervical carcinoma.More
recently Yeasmin reported another stage IA1 squamous cell carcinoma
with widespread bilateral pelvic lymph node metastases. (Yeasmin
et al., 2009) Lee et al. (2006) also reported a case of a 63 year old with
b1 mm invasion depth of disease but with supraclavicular lymph
nodemetastasis and Kang et al. (2009)reported a case of stage IA1 squa-
mous cervical carcinoma with invasion of less than 1 mm without
lymphovascular involvement but with unilateral ovarian metastasis.Table 1
Summary of previous reports of metastasis in microscopic cervical cancer.
Cervical cancer diagnosis Reported meta
IA1 cervical adenocarcinoma Bilateral pelvic
IA1, no capillary space involvement Lymph node
Multifocal microinvasive squamous cell cervical carcinoma Lymph node
IA1 squamous cell carcinoma Bilateral pelvic
IA1 squamous cervical carcinoma with negative LVSI Supraclavicula
IA1 squamous cervical carcinoma Unilateral ovar
IA2 cervical adeno-squamous carcinoma Myometrium j
IB1 Benign endom
IA1 cervical adenocarcinoma vaginal stump
IA GI recurrenceYoung et al. (1993) also reported a case of unilateral ovarian Stage IA1
squamous cell carcinoma metastasis in 1993.
This case demonstrates that when the uterus is preserved we must
also consider the possibility of a recurrence involving the corpus of the
uterus. Such recurrences were previously not seen because all radical
treatments treat or remove the uterus. Our case of uterine metastasis of
stage IA1 cervical squamous carcinoma adds to the debate about the op-
timal management of very early cervical cancer. In conservatively man-
aged patients, the risk of uterine corpus metastases and recurrence hasstasis Reference
lymph node Dhingra et al. (2008)
Elliott et al. (2000)
Gadducci et al. (2013)
lymph node Kang et al. (2009)
r lymph node and lung Lee et al. (2006)
ian Lee et al. (2009, 1988)
ust underneath the peritoneum and ovarian Nagarsheth et al. (2000)
etrial polyp. Utsugi et al. (2001)
recurrence Young et al. (1993)
Zenatta et al. (2000)
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metrialmetastasis for a stage IA1 squamous cervical carcinoma is unclear.
Other cases of cervical carcinoma metastasis to the uterine corpus have
been reported. Zenatta et al. (2000) reported a case of IA2 cervical
adenosquamous carcinoma which was treated conservatively with
cone biopsy and pelvic lymphadenectomy and presented 3 years later
with recurrence of carcinoma involving the myometrium just under-
neath the peritoneumandovarianmetastases. Another case ofmetastasis
of cervical carcinoma to the uterine corpuswas reported by Dhingra et al.
(2008) in 2008. Dhingra et al. described ametastasis of stage IB1 cervical
squamous cell carcinoma to a benign endometrial polyp (Table 1).
We believe this case also raises the question of the mechanism of
cervical carcinoma metastasis to the uterine corpus. There is no evi-
dence to suggest that multifocal disease is associated with any higher
risk of metastasis compared to unifocal lesions. Given that the disease
was superﬁcial we question whether cervical carcinoma dispersion
into the uterus could be caused by the previous local excision.
Conservative treatment of microinvasive cervical carcinoma is ex-
tremely important for patients in whom fertility preservation is re-
quired. However a small number of cases of extracervical metastasis
have now been described and this must be considered. This small num-
ber of cases must be offset however by the large numbers of women
who present with microinvasive disease each year, and clearly treat-
ment must be appropriate and commensurate with risk. A recent
review11 evaluated the various tissue biomarkers to predict the clinical
outcome of patients with cervical carcinoma; this included studies
which assessed DNA ploidy, cell-cycle and apoptosis-regulatory pro-
teins, epidermal growth factor receptor, vascular endothelial growth
factor [VEGF], cyclooxygenase-2, signal transducer and activator of tran-
scription, human papilloma virus [HPV] status, tumour hypoxia, tumour
inﬁltrating lymphocytes [TIL], microarray technology and microRNA.
The review concluded that the presence of HPV-18 genotype and an
elevated VEGF expression are poor prognostic factors in women with
early disease treated with primary surgery, however the prognostic rel-
evance of biological tissue factors is still unclear in view of the limita-
tions and heterogeneity of studies.Therefore identifying which group of women with microinvasive
disease are at risk of either lymph node or uterine corpus metastasis
which would thus allow greater stratiﬁcation of treatment remains a
high priorityConﬂict of interest
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